FDA Inspection 1324116 — Piotr Drobinski, M.D.
The FDA completed an inspection of Piotr Drobinski, M.D. on May 28, 2026 in Chojnice. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 28, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chojnice (Poland)
Additional Details
Clinical Investigator (CI)